In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-10 of 10 for your search:
Cancer Type/Condition:  T-cell childhood acute lymphoblastic leukemia
Stage/Subtype:  T-cell childhood acute lymphoblastic leukemia
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and under at diagnosis
Sponsor: NCI, Other
Protocol IDs: CDR0000573996, COG-AALL0631, AALL0631, NCT00557193

2.

Phase: Phase III
Type: Behavioral study, Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: NCI-2009-00307, AALL0434, CDR0000514500, COG-AALL0434, U01CA98543, NCT00408005

3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: T2009-003, NCT01483690

4.

Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 31
Sponsor: NCI, Other
Protocol IDs: AALL07P1, CDR0000638413, COG-AALL07P1, NCT00873093

5.

Phase: Phase II
Type: Treatment
Status: Active
Age: 8 to 75
Sponsor: NHLBI
Protocol IDs: 090087, 09-H-0087, NCT00859586

6.

Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCT00866749

7.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2009-0717, NCT01094860

8.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 months to 21 years
Sponsor: NCI
Protocol IDs: NCI-2011-02679, ADVL1114, COG_ADVL1114, CDR0000703889, U01CA097452, NCT01403415

9.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: CDR0000570260, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, CCLG-LK-2006-10, NCT00550992

10.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under
Sponsor: Other
Protocol IDs: SIR-MO-1101, 2012-0361, NCT01658007
New Search